MEDICAL SCIENCE MONITOR, vol.12, no.8, 2006 (SCI-Expanded)
Background: Methotrexate (MTX), a folic acid antagonist, is widely used as a cytotoxic chemotherapeutic agent for malignancies as well as in the treatment of various inflammatory diseases. The efficacy of this agent is often limited by severe side effects and toxic conditions. The present study was undertaken to determine whether N-acetylcysteine (NAC), as a potent antioxidant Compound, could ameliorate MTX-induced oxidative liver damage.